ArticleThe Journal of investigative dermatology2014

Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.

Linda Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.